Tykerb –Lapatinib - A Targeted Biologic...

Tykerb (lapatinib) is a targeted biologic therapy given as treatment for HER2 positive metastatic breast cancer. Tykerb can be taken with Xeloda, another oral chemotherapy drug, to extend survival and prevent the progression of advanced breast cancer. Read about how Tykerb works, possible side effects and drug interactions.

Source: About.com Breast Cancer - November 29, 2015 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news